Zhiming Li - SINOPHARM Insider

SINOPHARM -- Hong Kong Stock  

HKD 30.75  0.1  0.33%

President, Executive Director and Member of Strategy and Investment Committee

Mr. Li Zhiming is an Executive Chairman of the Board, Deputy Secretary of Party Committee of Sinopharm Group Co. Ltd. Mr. Li joined the Company in May 2010 as the vice President, and has served as the President and executive Director since November 2013 and January 2014, respectively. Mr. Li was the chief legal advisor of the Company from October 2012 to January 2014, and the secretary of disciplinary committee and chairman of labor union of the Company from November 2012 to October 2013. He was the deputy secretary of the Party Committee of the Company since November 2012. He has more than 34 years of working experience, over 30 years of which is management experience in the pharmaceutical and healthcare products industry. Mr. Li graduated from the Xinjiang Commerce College with associate degree and a major in finance and accounting in July 1981, and graduated from the economic management discipline of the Urumqi Branch of Xian Military Academy with associate degree in July 1997. Mr. Li was qualified as a senior economist. Mr. Li was the deputy director of finance department of Xinjiang New Special Ethnic Drug Store, deputy general manager and chief accountant of Xinjiang Pharmaceutical Industry and Trade Company, deputy general manager and chief accountant of Xinjiang New Special Ethnic Drug Corporationrationration, and deputy director of the office of the preparatory and leading group of Xinjiang Pharmaceutical Administration Bureau steering the construction of the group entity from July 1985 to July 1996. Mr. Li was general manager, chairman of the board of directors, secretary of the Party Committee of Xinjiang New Special Ethnic Drug Corporationrationration, and the director, general manager, vice chairman, chairman, and secretary of the Party Committee of Xinjiang Pharmaceutical Group Company from July 1996 to February 2016. Mr. Li is currently chairman of Sinopharm Group Xinjiang Medicines Co., Ltd.,
Age: 53  President Since 2017      
86 21 2305 2666  http://www.sinopharmholding.com/En

Management Efficiency

The company has return on total asset (ROA) of 4.16 % which means that it generated profit of $4.16 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 15.8 % meaning that it generated $15.8 on every $100 dollars invested by stockholders.
The company has accumulated 6.57 B in total debt with debt to equity ratio (D/E) of 90.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. SINOPHARM has Current Ratio of 1.23 suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Sinopharm Group Co.Ltd., together with its subsidiaries, distributes pharmaceutical and healthcare solutions in the People?s Republic of China. SINOPHARM (1099) is traded on Hong Kong Stock Exchange in Hong Kong. It is located in Sinopharm Group Co., Ltd.Shanghai, and employs 55,869 people.

Did you try this?

Run Content Syndication Now

Content Syndication

Quickly integrate customizable finance content to your own investment portal
Hide  View All  NextLaunch Content Syndication
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add SINOPHARM to your portfolio

Top Management

SINOPHARM Leadership Team
Jindong Deng, Director
Hailiang Liu, Director
Tze Yu, Director
Fang Yao, Executive
Guangpu Li, President
Yong Liu, VP
Qunbin Wang, Director
Yuhua Li, Director
Bin Zhou, Director
Junyu Guo, President
Lulin She, Chairman
Ping Ma, Director
Wanyong Lian, Executive
Qiyu Chen, Director
Ling Li, Director
Deyong Wen, Director
Zhiming Li, President
Zheng Liu, Director
Fumin Zhuo, Director
Xiuchang Jiang, CFO
Wee Tan, Director
Jun Lu, President
Yulin Wei, President
Chang Lyu, Director
Yijian Wu, Director
Wanjun Ma, President
Guangfu Li, President
Dongjiu Li, Director
Shuangjun Xu, President
Wei Liu, Executive, Ph.D
Zhongxi Cai, President, Ph.D
Qi Chen, Chairman

Stock Performance

SINOPHARM Performance Indicators